Modern compounding standards are defined by regulatory alignment, structured quality systems, documented testing, and controlled release procedures. In Strive’s webinar Setting the Standard in Compounding, Andrea Daniels, PharmD, outlines how these operational systems function within a compounding environment. For providers, understanding these systems helps clarify how pharmacies verify ingredients, monitor environments, evaluate sterile preparations, and review documentation before distribution pursuant to a valid prescription.
How Do Accreditation and Oversight Support Compounding Operations?
Compounding pharmacies operate under State Board of Pharmacy oversight and in accordance with applicable USP standards. The webinar also reviewed voluntary accreditation as an added accountability layer.
Certifications discussed:
These designations involve external evaluation of policies, procedures, and documentation.
Accreditation reflects a structured review. It also reinforces internal accountability.
The session provides further detail on how these frameworks integrate into daily operations.
What Is the Role of Compliance and Quality Assurance?
Operational standards rely on defined internal oversight.
Two functions were highlighted:
Compliance
The compliance team reviews regulatory alignment, formulation pathways, and documentation standards. This includes a review of educational and labeling materials.
Quality Assurance
The quality assurance team evaluates:
- Environmental monitoring
- Compounding practices
- Final preparation review
- Documentation verification
These teams support structured operational control.
What Testing Categories Were Reviewed?
The webinar outlined three primary testing categories:
- Sterility testing
- Endotoxin testing
- Potency verification
Sterility Testing
Evaluates whether a sterile preparation shows microbial growth under controlled laboratory conditions.
Endotoxin Testing
Assesses whether endotoxin levels fall below defined limits for that product type.
Potency Verification
Assesses whether the measured concentration aligns with labeled specifications.
The session discusses how testing supports batch review before release.
What Is a Certificate of Analysis (COA)?
A Certificate of Analysis verifies the identity, purity, potency, and quality specifications for a raw ingredient.
COAs support ingredient traceability.
The webinar described how documentation allows trace-back to ingredient lots when needed.
What Internal Quality Controls Were Highlighted?
In addition to third-party testing, the session referenced:
- Glove fingertip testing
- Surface testing
- Visual inspection
- Fill verification
- Batch quarantine
What Is Batch Quarantine?
Batch quarantine refers to holding a preparation until required testing and documentation review are completed.
Release occurs only after the pharmacist and quality review.
How Does Automation Support Operational Consistency?
Automation was presented as part of modernization.
Examples discussed:
- Tableting systems
- Encapsulation equipment
- Bottling automation
- Sterile preparation support
Automation supports repeatability within structured workflows.
The webinar provides additional context around these systems.
Frequently Asked Questions
Are compounded medications reviewed by the FDA?
Compounded medications are prepared for individual patient needs pursuant to a valid prescription and are not individually reviewed or approved by the FDA.
What documentation may be available to providers?
Providers may request accreditation information, certificates of analysis, and testing summaries.
Why is quarantine part of the workflow?
Quarantine ensures testing and documentation review occur before distribution.
Clinical Considerations for Providers
When reviewing compounding infrastructure, consider:
When It May Be Considered
- Patients requiring customized strengths
- Situations involving excipient sensitivities
- Allergies to fillers or inactive ingredients
Monitoring Considerations
- Clinical follow-up schedule
- Dose evaluation
Documentation Considerations
- Valid prescription
- Clinical rationale
Patient Discussion
- Clarify regulatory distinctions
- Review possible side effects
- Outline follow-up expectations
Access the Full Webinar
This article highlights key themes from Setting the Standard in Compounding: Choosing the Right Partner, presented by Andrea Daniels, PharmD.
Watch the full session in the video above for a deeper discussion of accreditation, testing workflows, automation, and quality oversight in modern compounding.
Interested in more provider education? Explore additional Strive Sessions webinars here.
Disclaimer:
Compounded medications are specially prepared for individual patient needs based on a valid prescription and, as such, are not reviewed or approved by the U.S. Food and Drug Administration (FDA) for safety or efficacy. These statements have not been evaluated by the FDA.
